Development Level

Tbio 2 | 10,625
Tclin 1 | 602

IMPC Term

preweaning lethality, incomple... 1 | 260

Disease

lung cancer 3 | 4,466
non-small cell lung cancer 3 | 2,798
ovarian cancer 3 | 8,484
group 3 medulloblastoma 2 | 2,254
interstitial cystitis 2 | 2,299
invasive ductal carcinoma 2 | 2,950
lung adenocarcinoma 2 | 2,713
pituitary cancer 2 | 1,972
psoriasis 2 | 6,685
tuberculosis 2 | 1,557
Alcohol dependence 1 | 107
Allergic rhinitis 1 | 91
Amnestic disorder 1 | 37
Anxiety Disorders 1 | 37
Arthritic Pain 1 | 5
Attention deficit hyperactivity disorder 1 | 156
Backache 1 | 8
Breast cancer 1 | 3,094
Cancer 1 | 2,346
Cannabis dependence 1 | 18
Catalepsy 1 | 15
Chemotherapy-induced nausea and vomiting 1 | 18
Cocaine-Related Disorders 1 | 88
Common cold 1 | 63
Endometriosis 1 | 535
Epilepsy 1 | 346
Epilepsy, Temporal Lobe 1 | 23
Fever 1 | 34
Gout 1 | 93
Headache disorder 1 | 20
Huntington Disease 1 | 12
Huntington's disease 1 | 72
Hyperalgesia 1 | 71
Hypotension 1 | 53
Hypothermia, natural 1 | 12
IGA Glomerulonephritis 1 | 454
Influenza-like symptoms 1 | 17
Joint pain 1 | 8
Liver Cirrhosis 1 | 101
Liver Cirrhosis, Experimental 1 | 108
Lupus erythematosus 1 | 80
Marijuana Abuse 1 | 8
Metabolic syndrome X 1 | 155
Migraine 1 | 79
Movement Disorders 1 | 21
Multiple Sclerosis 1 | 498
Nerve Degeneration 1 | 73
Nicotine dependence 1 | 53
Obesity 1 | 616
Opiate dependence 1 | 12
Pain 1 | 70
Pain Treatment Adjunct 1 | 3
Pain agnosia 1 | 99
Pancreatic Neoplasm 1 | 79
Pancreatitis 1 | 97
Parkinson's disease 1 | 364
Prostatic Neoplasms 1 | 471
Rhabdomyosarcoma 1 | 29
Schizophrenia 1 | 501
Seizures 1 | 95
Sinus headache 1 | 17
Status Epilepticus 1 | 85
Substance Withdrawal Syndrome 1 | 52
Substance abuse 1 | 55
Substance-Related Disorders 1 | 114
Tension-type headache 1 | 10
Toothache 1 | 6
Toxic encephalopathy 1 | 131
Transient tic disorder 1 | 2
Tularemia 1 | 22
Waldenstrons macroglobulinemia 1 | 765
Warsaw breakage syndrome 1 | 12
Weight Gain 1 | 87
Withdrawal disorder 1 | 19
aldosterone-producing adenoma 1 | 664
astrocytic glioma 1 | 2,241
chronic lymphosyte leukemia 1 | 232
colon cancer 1 | 1,475
cutaneous lupus erythematosus 1 | 1,056
cystic fibrosis 1 | 1,665
dermatomyositis 1 | 933
diabetes mellitus 1 | 1,663
ductal carcinoma in situ 1 | 1,745
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
hepatocellular carcinoma 1 | 532
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
medulloblastoma 1 | 1,524
mucosa-associated lymphoid tissue lymphoma 1 | 480
oligodendroglioma 1 | 2,849
osteosarcoma 1 | 7,933
post-traumatic stress disorder 1 | 45
posterior fossa group A ependymoma 1 | 1,511
primary Sjogren syndrome 1 | 789
primary pancreatic ductal adenocarcinoma 1 | 1,271
sarcoidosis 1 | 358
severe Alzheimer's disease 1 | 49
subependymal giant cell astrocytoma 1 | 2,287
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444

Target Family

Epigenetic 1 | 242
GPCR 1 | 406
Non-IDG 1 | 11,971

Grant Application

5R01DA003672-31 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Cannabinoid receptor 1 CNR1 Tclin GPCR -3.68588 5020.0 389
Chromobox protein homolog 1 CBX1 Tbio Epigenetic -2.30071 197.0 232